Terveystalo (TTALO) Investor presentation summary

Key performance highlights

• Recorded 7.2 million customer visits and 2.7 million unique users in 2025, with 1.2 million using digital services 24/7.

• Revenue for the last twelve months (Q2/26) was €1,212 million, with adjusted EBIT of €132 million and EPS of €0.72.

• Net debt to adjusted EBITDA stood at 2.5, and the brand was ranked #1 among consumer health brands.

• Net Promoter Scores were 88 for clinics and 96 for hospitals, with a Patient Enablement Index of 75%.

Strategic initiatives and growth

• Focus shifted from optimizing profitability to targeted, profitable growth through the ARC strategy.

• Service offering transitioned to bundled, transparent, and continuous care products, with more digital delivery.

• Emphasis on proactive customer relationship management and lifecycle engagement.

• AI and data-driven approaches support customer-centric growth and access.

M&A and portfolio development

• Acquisition of Silmäasema strengthens position in eye health and increases focus on consumer-driven services.

• Hohde dental business acquisition expected to close in Q3, supporting growth in selected specialties.

• Integrated model in eye health creates cross-selling opportunities and synergy potential.